Journal
AUTOPHAGY
Volume 15, Issue 11, Pages 1882-1898Publisher
TAYLOR & FRANCIS INC
DOI: 10.1080/15548627.2019.1596482
Keywords
FUNDC1; insulin resistance; MAPK; mitochondrial QC; mitophagy; obesity
Categories
Funding
- Beijing Natural Science Foundation of China [5161002]
- Chinese Academy of Sciences Key project of Frontier Science [QYZDJSSW-SMC004]
- Natural Science Foundation of China [31790404]
- Special Fund for Strategic Pilot Technology Chinese Academy of Sciences [XDPB1002]
- China postdoctoral grant [2016M591255]
Ask authors/readers for more resources
There is overwhelming evidence for an association between impaired mitochondrial function and metabolic syndrome. Mitophagy, a process that selectively removes damaged mitochondria via a specialized form of autophagy, is essential for mitochondrial quality control (mitochondrial QC) and metabolic homeostasis. We thus addressed the potential role of defective mitophagy in the pathogenesis of metabolic disorders. Mice lacking Fundc1, a newly characterized mitophagy receptor, develop more severe obesity and insulin resistance when fed a high-fat diet (HFD). Ablation of Fundc1 results in defective mitophagy and impaired mitochondrial QC in vitro and in white adipose tissue (WAT). In addition, there is more pronounced WAT remodeling with more adipose tissue-associated macrophages infiltration, more M1 macrophage polarization and thus an elevated inflammatory response. Mechanistically, hyperactivation of MAPK/JNK leads to insulin insensitivity, which can be inhibited by knocking out Mapk8/Jnk1 in fundc1 KO mice. Our results demonstrate that dysregulated mitochondrial QC due to defective mitophagy receptor FUNDC1 links with metabolic disorders via MAPK signaling and inflammatory responses.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available